BioSpace News Archive

The global intragastric balloons market 2018-2022 is expected to post a CAGR of more than 25% during the forecast period, according to the latest market research report by Technavio.

Cerveau Technologies Inc., today announced a research collaboration agreement with Ionis Pharmaceuticals, Inc. for use of [F-18]MK-6240, an investigational imaging agent to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain

Technavio analysts forecast the global endometrial cancer therapeutics market to grow at a CAGR of over 5% during the forecast period, according to their latest market research report.

Clinical Stage Immuno-Oncology Company Releases Media Platform to Provide Background Information on Lead Technology

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced today that the Food and Drug Administration (FDA) has lifted the clinical hold for the Company’s Duchenne muscular dystrophy (DMD) micro-dystrophin gene therapy program.

According to data compiled by Grand View Research, the global legal cannabis market was valued at USD 9.3 Billion in 2016. Based on the data, the market is expected to grow at a CAGR of 34.6% during the forecast period of 2018 to 2025.

Quantzig, a pure-play analytics solutions provider, has announced the completion of their latest engagement on real world evidence for a leading new cancer drugs manufacturer.

Rob Hayes, president and CEO of BASIC (Benefit Administrative Services International Corporation), has been honored by WEX Health with a 2017 Partner Excellence Award for outstanding business achievements.

Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiroa and Xienceb drug-eluting stents (DES).

Advanced Bifurcation Systems (ABS), a clinical-stage medical device company with a patented bifurcation stenting platform to standardize the treatment of all bifurcation lesions in coronary angioplasties, is showcasing its innovative platform at the ABS booth at Transcatheter Cardiovascular Therapeutics (TCT)